Form 4 for AXGN Axogen, Inc.
Accepted 2022-12-16 00:00:00 ET · period of report 2022-12-15 · accession 0000805928-22-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-16 | 2022-12-15 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $5.09 | +26.7K | 1.01M | +3% | +$136.1K |
| D | 2022-12-16 | 2022-12-15 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $0.00 | -26.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | M | A | 26,746 | $5.09 | 1,008,295 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-12-15 | M | D | 26,746 | $0.00 | 0 | D | $5.09 · 2016-12-28 to 2022-12-28 | 26,746 Common Stock |